688799 华纳药厂
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)10.9149.31812.73011.88615.007
总资产报酬率 ROA (%)7.9057.08810.0979.60511.826
投入资产回报率 ROIC (%)9.2928.52012.04411.34314.505

边际利润分析
销售毛利率 (%)60.79561.63064.78567.71272.385
营业利润率 (%)19.94111.44916.54915.16315.864
息税前利润/营业总收入 (%)19.16210.23015.18414.49415.356
净利润/营业总收入 (%)18.1389.82113.47313.41314.021

收益指标分析
经营活动净收益/利润总额(%)55.22696.83596.90293.02291.016
价值变动净收益/利润总额(%)40.476-11.5431.5594.0910.948
营业外收支净额/利润总额(%)-0.321-0.055-3.147-0.534-1.034

偿债能力分析
流动比率 (X)4.2613.4214.0134.2344.646
速动比率 (X)3.0332.4362.9343.0833.488
资产负债率 (%)28.36325.90118.77417.43917.695
带息债务/全部投入资本 (%)13.5786.2772.3762.068-0.114
股东权益/带息债务 (%)605.5691,411.6123,980.9374,575.411-84,720.728
股东权益/负债合计 (%)252.575283.082421.701455.722465.140
利息保障倍数 (X)-26.789-8.441-17.654-24.640-44.472

营运能力分析
应收账款周转天数 (天)45.22241.33439.24738.76236.980
存货周转天数 (天)261.134257.343250.413275.918277.521